Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Radiant Logistics
RLGT
$414M
| $1.18M | ﹤0.01% |
170,765
+4,192
| +3% | +$30.3K |
|
3277
InnovAge Holding
INNV
$1.46B
| $1.18M | ﹤0.01% |
+55,370
| New | +$1.27M |
|
3278
Cytosorbents Corp
CTSO
$24.2M
| $1.18M | ﹤0.01% |
155,639
-6,022
| -4% | -$50.7K |
|
3279
WisdomTree US High Dividend Fund
DHS
$1.6B
| $1.18M | ﹤0.01% |
15,031
+6,554
| +77% | +$517K |
|
3280
Cue Biopharma
CUE
$135M
| $1.17M | ﹤0.01% |
3,353
-314
| -9% | -$122K |
|
3281
argenx
ARGX
$52.5B
| $1.17M | ﹤0.01% |
3,884
-385
| -9% | -$109K |
|
|
VPU
3282
Vanguard Utilities ETF
VPU
$8.55B
| $1.16M | ﹤0.01% |
8,389
-2,768
| -25% | -$397K |
|
3283
Energy Transfer Partners
ET
$72.1B
| $1.16M | ﹤0.01% |
109,449
+20,690
| +23% | +$198K |
|
3284
ACM Research
ACMR
$5.66B
| $1.16M | ﹤0.01% |
34,032
-14,892
| -30% | -$409K |
|
|
NPKI
3285
NPK International
NPKI
$1.2B
| $1.16M | ﹤0.01% |
334,751
-1,888
| -0.6% | -$6.41K |
|
3286
Citius Pharmaceuticals
CTXR
$20.2M
| $1.16M | ﹤0.01% |
13,292
+11,191
| +533% | +$673K |
|
3287
TherapeuticsMD
TXMD
$24.1M
| $1.16M | ﹤0.01% |
19,443
-4,317
| -18% | -$262K |
|
3288
US Global Jets ETF
JETS
$831M
| $1.16M | ﹤0.01% |
47,815
| – | – |
|
3289
Caesarstone
CSTE
$110M
| $1.15M | ﹤0.01% |
77,824
+6,465
| +9% | +$97.7K |
|
|
PFBI
3290
DELISTED
Premier Financial Bancorp
PFBI
| $1.15M | ﹤0.01% |
68,209
-900
| -1% | -$16.7K |
|
3291
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$971M
| $1.15M | ﹤0.01% |
20,909
+3,423
| +20% | +$185K |
|
3292
Noodles & Co
NDLS
$107M
| $1.15M | ﹤0.01% |
11,476
+585
| +5% | +$54.4K |
|
3293
Shore Bancshares
SHBI
$805M
| $1.15M | ﹤0.01% |
68,425
-31,644
| -32% | -$536K |
|
3294
Grid Dynamics Holdings
GDYN
$626M
| $1.14M | ﹤0.01% |
76,108
+3,867
| +5% | +$60.6K |
|
3295
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
| $1.14M | ﹤0.01% |
20,133
| – | – |
|
|
FLXN
3296
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.14M | ﹤0.01% |
138,297
-30,524
| -18% | -$260K |
|
|
TA
3297
DELISTED
TravelCenters of America LLC
TA
| $1.14M | ﹤0.01% |
38,929
+30,882
| +384% | +$860K |
|
3298
ARK Genomic Revolution ETF
ARKG
$1.74B
| $1.14M | ﹤0.01% |
12,294
+5,417
| +79% | +$461K |
|
|
ONIT
3299
Onity Group
ONIT
$328M
| $1.14M | ﹤0.01% |
36,680
+20,021
| +120% | +$609K |
|
|
CWBC
3300
Community West Bancshares
CWBC
$707M
| $1.14M | ﹤0.01% |
56,333
-28,715
| -34% | -$574K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.